Tobacco use behaviors and views on engaging in clinical trials for tobacco cessation among individuals who experience homelessness.

Contingency management People experiencing homelessness Tobacco cessation

Journal

Contemporary clinical trials communications
ISSN: 2451-8654
Titre abrégé: Contemp Clin Trials Commun
Pays: Netherlands
ID NLM: 101671157

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 12 09 2022
revised: 31 01 2023
accepted: 17 02 2023
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 1 3 2023
Statut: epublish

Résumé

Clinical trials that include contingency management for smoking cessation have shown promising results for short-term quitting, but none have explored this approach for long-term abstinence in people experiencing homelessness. We designed a clinical trial of an extended contingency management intervention for smoking cessation for people experiencing homelessness. This study has two aims: (1) to explore tobacco use behaviors, and views toward smoking cessation, and (2) to explore factors influencing acceptability of engaging in such a trial in a sample of adult smokers experiencing homelessness. We administered a questionnaire to obtain information on tobacco use behaviors and conducted in-depth, semi-structured interviews with 26 patients who had experienced homelessness and were patients at a safety net health clinic in San Francisco, California, where we planned to pilot the intervention. We obtained information on triggers for tobacco use, prior cessation experiences, attitudes toward cessation, attitudes toward engaging in a clinical trial for cessation, and factors that might influence participation in our proposed contingency management clinical trial. We analyzed transcripts using content analysis. Participants described the normative experiences of smoking, co-occurring substance use, and the use of tobacco to relieve stress as barriers to quitting. Despite these barriers, most participants had attempted to quit smoking and most were interested in engaging in a clinical trial as a method to quit smoking. Participants noted that desirable features of the trial include: receiving financial incentives to quit smoking, having a flexible visit schedule, having the study site be easily accessible, and having navigators with lived experiences of homelessness. A patient-centric clinical trial design that includes incentives, flexible visits and navigators from the community may increase feasibility of engaging in clinical trials among individuals experiencing homelessness.

Sections du résumé

Background UNASSIGNED
Clinical trials that include contingency management for smoking cessation have shown promising results for short-term quitting, but none have explored this approach for long-term abstinence in people experiencing homelessness. We designed a clinical trial of an extended contingency management intervention for smoking cessation for people experiencing homelessness. This study has two aims: (1) to explore tobacco use behaviors, and views toward smoking cessation, and (2) to explore factors influencing acceptability of engaging in such a trial in a sample of adult smokers experiencing homelessness.
Methods UNASSIGNED
We administered a questionnaire to obtain information on tobacco use behaviors and conducted in-depth, semi-structured interviews with 26 patients who had experienced homelessness and were patients at a safety net health clinic in San Francisco, California, where we planned to pilot the intervention. We obtained information on triggers for tobacco use, prior cessation experiences, attitudes toward cessation, attitudes toward engaging in a clinical trial for cessation, and factors that might influence participation in our proposed contingency management clinical trial. We analyzed transcripts using content analysis.
Results UNASSIGNED
Participants described the normative experiences of smoking, co-occurring substance use, and the use of tobacco to relieve stress as barriers to quitting. Despite these barriers, most participants had attempted to quit smoking and most were interested in engaging in a clinical trial as a method to quit smoking. Participants noted that desirable features of the trial include: receiving financial incentives to quit smoking, having a flexible visit schedule, having the study site be easily accessible, and having navigators with lived experiences of homelessness.
Conclusion UNASSIGNED
A patient-centric clinical trial design that includes incentives, flexible visits and navigators from the community may increase feasibility of engaging in clinical trials among individuals experiencing homelessness.

Identifiants

pubmed: 36852099
doi: 10.1016/j.conctc.2023.101094
pii: S2451-8654(23)00040-6
pmc: PMC9958417
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101094

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Addiction. 2009 Jun;104(6):1043-52
pubmed: 19392908
J Consult Clin Psychol. 2001 Apr;69(2):295-304
pubmed: 11393606
Nicotine Tob Res. 2020 Aug 24;22(9):1662-1663
pubmed: 32343816
Curr Probl Cardiol. 2019 May;44(5):148-172
pubmed: 30545650
Am J Public Health. 2015 Jun;105(6):1189-97
pubmed: 25521869
Am J Public Health. 2011 Dec;101(12):2349-56
pubmed: 21653904
Am J Health Promot. 2020 Jan;34(1):32-41
pubmed: 31537083
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742
pubmed: 33211681
Acad Psychiatry. 2007 Sep-Oct;31(5):402-5
pubmed: 17875625
Am J Health Promot. 2018 Feb;32(2):381-391
pubmed: 28893086
BMC Public Health. 2019 May 24;19(1):635
pubmed: 31126265
Annu Rev Public Health. 2010;31:297-314 1p following 314
pubmed: 20001818
Addiction. 2013 Nov;108(11):2009-18
pubmed: 23834157
Int J Drug Policy. 2021 Dec;98:103377
pubmed: 34481110
Addict Behav. 2019 Aug;95:197-201
pubmed: 30959414
Am J Health Promot. 2017 May;31(3):243-250
pubmed: 26559719
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Cochrane Database Syst Rev. 2015 May 18;(5):CD004307
pubmed: 25983287
J Appl Behav Anal. 1986 Summer;19(2):197-202
pubmed: 3733589
Addiction. 2013 Jun;108(6):1136-44
pubmed: 23510102
Psychol Addict Behav. 2018 Mar;32(2):141-148
pubmed: 29461070
Prev Med. 2012 Nov;55 Suppl:S2-6
pubmed: 22554884
Nicotine Tob Res. 2006 Oct;8(5):689-99
pubmed: 17008196
Cochrane Database Syst Rev. 2020 Dec 3;12:CD013413
pubmed: 33284989
JAMA Intern Med. 2013 Feb 11;173(3):189-95
pubmed: 23318302
Nicotine Tob Res. 2021 Jan 7;23(1):99-106
pubmed: 31993637
CMAJ. 2020 Jun 29;192(26):E716-E719
pubmed: 32601252
Addict Behav. 1982;7(4):403-12
pubmed: 7183194
Nicotine Tob Res. 2018 Nov 15;20(12):1442-1450
pubmed: 29059442
Int J Environ Res Public Health. 2022 Mar 18;19(6):
pubmed: 35329321
N Engl J Med. 2013 Jul 18;369(3):201-4
pubmed: 23863048
JMIR Mhealth Uhealth. 2019 Jun 04;7(6):e13162
pubmed: 31165717
J Am Coll Cardiol. 2016 Aug 23;68(8):777-85
pubmed: 27539168
Clin Trials. 2011 Dec;8(6):744-54
pubmed: 22167112
Trials. 2017 Jul 5;18(1):305
pubmed: 28679430

Auteurs

Joshua Miller (J)

Center for Tobacco Control Research and Education, University of California, San Francisco, USA.

Jordan Cuby (J)

Division of General Internal Medicine, University of California, San Francisco, USA.

Sharon M Hall (SM)

Department of Psychiatry, And Weill Institute for Neurosciences, University of California, San Francisco, USA.

Maxine Stitzer (M)

Friends Research Institute, USA.

Margot Kushel (M)

Center for Vulnerable Populations, University of California, San Francisco, USA.

Donna Appiah (D)

School of Medicine, University of California, San Francisco, USA.

Maya Vijayaraghavan (M)

Center for Tobacco Control Research and Education, University of California, San Francisco, USA.
Division of General Internal Medicine, University of California, San Francisco, USA.
Center for Vulnerable Populations, University of California, San Francisco, USA.

Classifications MeSH